Financials data is unavailable for this security.
View more
Year on year Novocure Ltd 's revenues fell -5.30%from 537.84m to 509.34m. In addition, the company has been unable to reduce the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percentage of sales). This has contributed to a 123.75% reduction in net income from a loss of 92.53m to a larger loss of 207.04m.
| Gross margin | 76.42% |
|---|---|
| Net profit margin | -25.93% |
| Operating margin | -27.51% |
| Return on assets | -12.65% |
|---|---|
| Return on equity | -39.70% |
| Return on investment | -20.29% |
More ▼
Cash flow in USDView more
In 2023, Novocure Ltd increased its cash reserves by 109.41%, or 126.73m. Cash Flow from Investing totalled 184.15m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 73.34m for operations while cash generated from financing totalled 15.79m.
| Cash flow per share | -1.29 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 3.34 |
|---|---|
| Tangible book value per share | 3.34 |
More ▼
Balance sheet in USDView more
| Current ratio | 1.49 |
|---|---|
| Quick ratio | 1.44 |
| Total debt/total equity | 1.81 |
|---|---|
| Total debt/total capital | 0.6446 |
More ▼
